Compare MXL & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXL | IART |
|---|---|---|
| Founded | 2003 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2010 | 1995 |
| Metric | MXL | IART |
|---|---|---|
| Price | $19.19 | $12.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | ★ $20.25 | $15.00 |
| AVG Volume (30 Days) | ★ 972.8K | 707.2K |
| Earning Date | 01-29-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $423,372,000.00 | ★ $1,642,966,000.00 |
| Revenue This Year | $30.54 | $3.26 |
| Revenue Next Year | $18.23 | $2.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.53 | 4.99 |
| 52 Week Low | $8.35 | $10.87 |
| 52 Week High | $25.73 | $27.13 |
| Indicator | MXL | IART |
|---|---|---|
| Relative Strength Index (RSI) | 59.03 | 47.79 |
| Support Level | $17.90 | $12.21 |
| Resistance Level | $19.12 | $13.53 |
| Average True Range (ATR) | 0.77 | 0.69 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 75.06 | 37.57 |
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.